Skip to content

Bhalla Narinder Pal

Reporting owner on Forms 3, 4 and 5, CIK 2109299.

Bhalla Narinder Pal reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Lexeo Therapeutics, Inc. CIK 1907108officer (Chief Medical Officer)12026-09-28

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Lexeo Therapeutics, Inc. Stock Option (right to buy), derivative2026-09-24A granted+54,750$054,750Form 4
Lexeo Therapeutics, Inc. Common Stock2026-09-14A granted+2,714$3.57984,908Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0002109299-26-000009 Lexeo Therapeutics, Inc.2026-09-28